Functional neuroimaging in child and adolescent psychiatry

Connecticut Medicine

Volumn 69, Issue 9, 2005, Pages 561-570

  Stevens, Michael C ^a,b  

^a INSTITUTE OF LIVING   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR; BRAIN BLOOD FLOW; BRAIN REGION; CHILD PSYCHIATRY; CLINICAL PRACTICE; COGNITION; EMOTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEMODYNAMICS; HUMAN; MAGNETOENCEPHALOGRAPHY; MAJOR DEPRESSION; MENTAL DISEASE; NEUROIMAGING; NEUROSCIENCE; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ADOLESCENT PSYCHIATRY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CHILD; CHILD PSYCHIATRY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; RESEARCH DESIGN;

EID: 26444566777     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Blake P, Johnson B, VanMeter JW: Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT): Clinical Applications. J Neuroophthalmol 2003; 23:34-41.
2. Wheless JW, Castillo E, Maggio V, et al: Magnetoencephalography (MEG) and magnetic source imaging (MSI). Neurologist 2004; 10:138-53.
3. Cohen MS, Bookheimer SY: Localization of brain function using magnetic resonance imaging. Trends Neurosci 1994; 17:268-77.
4. Ernst M and Rumsey JM: Functional neuroimaging in child psychiatry. Curr Psychiatry Rep 2000; 2:124-30.
5. Cunningham VJ, Gunn RN, Matthews JC: Quantification in positron emission tomography for research in pharmacology and drug development. Nucl Med Commun 2004; 25:643-6.
6. Calhoun VD, Pekar JJ, Pearlson GD: Alcohol intoxication effects on simulated driving: Exploring alcohol-dose effects on brain activation using functional MRI. Neuropsychopharmacology 2004; 29:2097-17.
7. Calhoun VD, Pekar JJ, McGinty VB, et al: Different activation dynamics in multiple neural systems during simulated driving. Hum Brain Mapp 2002; 16:158-67.
8. Wolbers T, Buchel C: Dissociable retrosplenial and hippocampal contributions to successful formation of survey representations. J Neurosci 2005; 25:3333-40.
9. Baumann S, Neff C, Fetzick S, et al: A virtual reality system for neurobehavioral and functional MRI studies. Cyberpsychol Behav 2003; 6:259-66.
10. Patel RS, Bowman FD, Rilling JK: A Bayesian approach to determining connectivity of the human brain. Hum Brain Mapp 2005.
11. Worsley KJ, Chen JI, Lerch J, et al: Comparing functional connectivity via thresholding correlations and singular value decomposition. Philos Trans R Soc Lond B Biol Sci 2005; 360:913-20.
12. Hampson M, Peterson BS, Skudlarski P, et al: Detection of functional connectivity using temporal correlations in MR images. Hum Brain Mapp 2002; 15:247-62.
13. Baillet S, Garnero L, Marin G, et al: Combined MEG and EEG source imaging by minimization of mutual information. IEEE Trans Biomed Eng 1999; 46:522-34.
14. Calhoun VD, Kiehl KA, Pearlson GD, et al: Neuronal chronometry of target detection: Fusion of hemody namic and event-related potential data. In press.
15. Verhoeven WM, Tuinier S: Two steps forward, one step back; paradigmatic changes in psychiatry. J Neural Transm 2001; 108:617-27.
16. Kaplan RF, Stevens M: A review of adult ADHD: a neuropsy chological and neuroimaging perspective. CNS Spectr 2002; 7:355-62.
17. Association AP: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994, Washington, DC: American Psychiatric Association.
18. Lahey BB, Applegate B, McBurnett K, et al: DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry 1994; 151:1673-85.
19. Denckla MB: Attention deficit hyperactivity disorder-residual type. J Child Neurol 1991; 6:S44-50.
20. Barkley RA: Attention-deficit hyperactivity disorder. Sci Am 1998; 279:66-71.
21. Milich R, Balentine AC, Lynam DR: ADHD combined type and ADHD predominantly inattentive type are distinct and unrelated disorders. Clin Psychol: Sci Pract 2001; 8:463-88.
22. Hinshaw SP: Is the inattentive type of ADHD a separate disorder? Clin Psychol: Sci Pract 2001; 8:498-501.
23. Barkley RA: The inattentive type of ADHD as a distinct disorder: What remains to be done. Clin Psychol: Sci Pract 2001; 8:489-501.
24. Quay HC, Routh DK, Shapiro SK: Psychopathology of childhood: From description to validation. Ann Rev Psychol 1987; 38:491-532.
25. Sonuga-Barke EJ: The dual pathway model of AD/HD: An elaboration of neuro-developmental characteristics. Neurosci Biobehav Rev 2003; 27:593-604.
26. Rubia K, Taylor A, Taylor E, et al: Synchronization, anticipation, and consistency in motor timing of children with dimensionally defined attention deficit hyperactivity behaviour. Percept Mot Skills 1999; 89:1237-58.
27. Durston S, Tottenham NT, Thomas KM, et al: Differential patterns of striatal activation in young children with and without ADHD. Biol Psychiatry 2003; 53:871-8.
28. Vaidya CJ, Austin G, Kirkorian G, et al: Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study. Proc Natl Acad Sci USA 1998; 95:14494-9.
29. Schulz KP, Fan J, Tang CY, et al: Response inhibition in adolescents diagnosed with attention deficit hyperactivity disorder during childhood: An event-related FMRI study. Am J Psychiatry 2004; 161:1650-7.
30. Tamm L, Menon V, Ringel J, et al: Event-related FMRI evidence of frontotemporal involvement in aberrant response inhibition and task switching in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2004; 43:1430-40.
31. Carter CS, Braver TS, Barch DM, et al: Anterior cingulate cortex, error detection, and the online monitoring of performance. Science 1998; 280:747-9.
32. Bush G, Frazier JA, Rauch SL, et al: Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol Psychiatry 1999; 45:1542-52.
33. Ernst M, Liebenauer LL, King AC, et al: Reduced brain metabolism in hyperactive girls. J Am Acad Child Adolesc Psychiatry 1994; 33:858-68.
34. Zametkin AJ, Liebenauer LL, Fitzgerald GA, et al: Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1993; 50:333-40.
35. Shafritz KM, Marchione KE, Gore JC, et al: The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder. Am J Psychiatry 2004; 161:1990-7.
36. Costello EJ, Mustillo S, Erkanli A, et al: Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 2003; 60:837-44.
37. Mayberg HS: Modulating dysfunctional limbic-cortical circuits in depression: Towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003; 65:193-207.
38. Sheline YI: Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry 2003; 54:338-52.
39. Baxter LR, Jr., Schwartz JM, Phelps ME, et al: Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989; 46:243-50.
40. Buchsbaum MS, Wu J, Siegel BV, et al: Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry 1997; 41:15-22.
41. Bench CJ, Friston KJ, Brown RG, et al: The anatomy of melancholia-focal abnormalities of cerebral blood flow in major depression. Psychol Med 1992; 22:607-15.
42. Drevets WC, Bogers W and Raichle ME: Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol 2002; 12:527-44.
43. Davidson RJ, Irwin W, Anderle MJ, et al: The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 2003; 160:64-75.
44. Mayberg HS, Lewis PJ, Regenold W, et al: Paralimbic hypoperfusion in unipolar depression. J Nucl Med 1994; 35:929-34.
45. Kusumakar V, MacMaster FP, Gates L, et al: Left medial temporal cytosolic choline in early onset depression. Can J Psychiatry 2001; 46:959-64.
46. Mirza Y, Tang J, Russell A, et al: Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. J Am Acad Child Adolesc Psychiatry 2004; 43:341-8.
47. Harrington R, Fudge H, Rutter M, et al: Adult outcomes of childhood and adolescent depression. I. Psychiatric status. Arch Gen Psychiatry 1990; 47:465-73.
48. Thomas KM, Drevets WC, Dahl RE, et al: Amygdala response to fearful faces in anxious and depressed children. Arch Gen Psychiatry 2001; 58:1057-63.
49. Tutus A, Kibar M, Sofuoglu S, et al: A technetium-99m hexamethylpropylene amine oxime brain single-photon emission tomography study in adolescent patients with major depressive disorder. Eur J Nucl Med 1998; 25:601-6.
50. Kowatch RA, Devous MD, Sr., Harvey DC, et al: ASPECTHMPAO study of regional cerebral blood flow in depressed adolescents and normal controls. Prog Neuropsychopharmacol Biol Psychiatry 1999; 23:643-56.
51. Giedd J: Brain development, IX: Human brain growth. Am J Psychiatry 1999; 156:4.
52. Casey BJ, Forman SD, Franzen P, et al: Sensitivity of prefrontal cortex to changes in target probability: A functional MRI study. Hum Brain Mapping 2001; 13:26-33.
53. Killgore WD, Oki M, Yurgelun-Todd DA: Sex-specific developmental changes in amygdala responses to affective faces. Neuroreport 2001; 12:427-33.
54. Carlson GA: The challenge of diagnosing depression in childhood and adolescence. J Affect Disord 2000; 61(Suppl)1:3-8.
55. Compas BE, Ey S, Grant KE: Taxonomy, assessment, and diagnosis of depression during adolescence. Psychol Bull 1993; 114:323-44.
56. Weiss B, Garber J: Developmental differences in the phenomenology of depression. Dev Psychopathol 2003; 15:403-30.
57. Carlson GA, Kashani JH: Phenomenology of major depression from childhood through adulthood: Analysis of three studies. Am J Psychiatry 1988; 145:1222-5.
58. Kovacs M, Akiskal HS, Gatsonis C, et al: Childhood-onset dysthymic disorder. Clinical features and prospective naturalistic outcome. Arch Gen Psychiatry 1994; 51:365-74.
59. Biederman J, Faraone S, Mick E, et al: Psychiatric comorbidity among referred juveniles with major depression: Fact or artifact? J Am Acad Child Adolesc Psychiatry 1995; 34:579-90.
60. Fombonne E: The epidemiology of autism: A review. Psychol Med 1999; 29:769-86.
61. Folstein SE, Rosen-Sheidley B: Genetics of autism: Complex aetiology for a heterogeneous disorder. Nat Rev Genet 2001; 2:943-55.
62. Acosta MT, Pearl PL: The neurobiology of autism: New pieces of the puzzle. Curr Neurol Neurosci Rep 2003; 3:149-56.
63. Schultz RT: Developmental deficits in social perception in autism: the role of the amygdala and fusiform face area. Int J Dev Neurosci 2005; 23:125-41.
64. Di Martino A, Castellanos FX: Functional neuroimaging of social cognition in pervasive developmental disorders: a brief review. Ann N Y Acad Sci 2003; 1008:256-60.
65. Adolphs R: Social cognition and the human brain. Trends Cogn Sci 1999; 3:469-79.
66. Adolphs R: The neurobiology of social cognition. Curr Opin Neurobiol 2001; 11:231-9.
67. Frith U: Mind blindness and the brain in autism. Neuron 2001; 32:969-79.
68. Happe F, Ehlers S, Fletcher P, et al: 'Theory of mind' in the brain. Evidence from a PET scan study of Asperger syndrome. Neuroreport 1996; 8:197-201.
69. Baron-Cohen S, Ring HA, Wheelwright S, et al: Social intelligence in the normal and autistic brain: An fMRI study. Eur J Neurosci 1999; 11:1891-8.
70. Schultz RT, Gauthier I, Klin A, et al: Abnormal ventral temporal cortical activity during face discrimination among individuals with autism and Asperger syndrome. Arch Gen Psychiatry 2000; 57:331-40.
71. Pierce K, Muller RA, Ambrose J, et al: Face processing occurs outside the fusiform 'face area' in autism: Evidence from functional MRI. Brain 2001; 124:2059-73.
72. Hadjikhani N, Joseph RM, Snyder J, et al: Activation of the fusiform gyrus when individuals with autism spectrum disorder view faces. Neuroimage 2004; 22:1141-50.
73. Hubl D, Boite S, Feineis-Matthews S, et al: Functional imbalance of visual pathways indicates alternative face processing strategies in autism. Neurology 2003; 61:1232-7.
74. Critchley HD, Daly EM, Bullmore ET, et al: The functional neuroanatomy of social behaviour: Changes in cerebral blood flow when people with autistic disorder process facial expressions. Brain 2000; 123(Pt 11):2203-12.
75. Ogai M, Matsumoto H, Suzuki K, et al: fMRI study of recognition of facial expressions in high-functioning autistic patients. Neuroreport 2003; 14:559-63.
76. Haznedar MM, Buchsbaum MS, Wei TC, et al: Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging. Am J Psychiatry 2000; 157:1994-2001.
77. Gervais H, Belin P, Boddaert N, et al: Abnormal cortical voice processing in autism. Nat Neurosci 2004; 7:801-2.
78. Mountz JM, Tolbert LC, Lill DW, et al: Functional deficits in autistic disorder: Characterization by technetium-99m-HMPAO and SPECT. J Nucl Med 1995; 36:1156-62.
79. Ohnishi T, Matsuda H, Hashimoto T, et al: Abnormal regional cerebral blood flow in childhood autism. Brain 2000; 123(Pt 9):1838-44.
80. Zilbovicius M, Boddaert N, Belin P, et al: Temporal lobe dysfunction in childhood autism: A PET study. Positron emission tomography. Am J Psychiatry 2000; 157:1988-93.
81. Ring HA, Baron-Cohen S, Wheelwright S, et al: Cerebral correlates of preserved cognitive skills in autism: A functional MRI study of embedded figures task performance. Brain 1999; 122(Pt 7):1305-15.
82. Luna B, Minshew NJ, Garver KE, et al: Neocortical system abnormalities in autism: An fMRI study of spatial working memory. Neurology 2002; 59:834-10.
83. Koshino H, Carpenter PA, Minshew NJ, et al: Functional connectivity in an fMRI working memory task in high-functioning autism. Neuroimage 2005; 24:810-21.
84. Grossman AW, Churchill JD, McKinney BC, et al: Experience effects on brain development: possible contributions to psychopathology. J Child Psychol Psychiatry 2003; 44:33-63.
85. Waddington JL, Youssef HA and Kinsella A: Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia. Psychol Med 1995; 25:849-57.
86. Pynoos RS, Steinberg AM, Ornitz EM, et al: Issues in the developmental neurobiology of traumatic stress. Ann N Y Acad Sci 1997; 821:176-93.
87. Johnson MH: Cortical plasticity in normal and abnormal cognitive development: Evidence and working hypotheses. Dev Psychopathol 1999; 11:419-37.
88. Calhoun VD, Adali T, Giuliani NR, et al: Method for multimodal analysis of independent source differences in schizophrenia: Combining gray matter structural and auditory oddball functional data. Hum Brain Mapp 2005.
89. Fuchs T: Neurobiology and psychotherapy: An emerging dialogue. Cur Opin Psychiatry 2004; 17:479-85.
90. Gabbard GO: A neurobiologically informed perspective on psychotherapy. Br J Psychiatry 2000; 177:117-22.
91. Liggan DY, Kay J: Some neurobiological aspects of psychotherapy. A review. J Psychother Pract Res 1999; 8:103-14.
92. Kandel ER: Biology and the future of psychoanalysis: A new intellectual framework for psychiatry revisited. Am J Psychiatry 1999; 156:505-24.
93. Bjorklund A, Lindvall O: Self-repair in the brain. Nature 2000; 405:892-3,895.
94. Gould E, Tanapat P, McEwen BS, et al: Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc Natl Acad Sci USA 1998; 95:3168-71.
95. Goldapple K, Segal Z, Garson C, et al: Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 2004; 61:34-41.
96. Martin SD, Martin E, Rai SS, et al: Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Arch Gen Psychiatry 2001; 58:641-8.
97. Brody AL, Saxena S, Stoessel P, et al: Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: Preliminary findings. Arch Gen Psychiatry 2001; 58:631-40.
98. Furmark T, Tillfors M, Marteinsdottir I, et al: Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry 2002; 59:425-33.
99. Paquette V, Levesque J, Mensour B, et al: Change the mind and you change the brain: Effects of cognitive-behavioral therapy on the neural correlates of spider phobia. Neuroimage 2003; 18:401-9.
100. Baxter LR, Jr., Schwartz JM, Bergman KS, et al: Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49:681-9.